Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
46 /100
MEDIUM RISK
Score updated Oct 13, 2026

SANA — Sana Biotechnology, Inc. Dilution Risk Tracker

Track SANA dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track SANA — Get alerts when the score changes →

As of October 13, 2026, Sana Biotechnology, Inc. (SANA) has a DilutionWatch DilutionScore of 46/100, rated MEDIUM dilution risk. Sana Biotechnology, Inc. has a market capitalization of $784.32M, 299.36M shares outstanding, 201 institutional holders tracked. Stored dilution-related fields include ATM program capacity of $50.00M.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
31
💰 Cash Runway
65
📊 Float Risk
42
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

⛅
Watch
Minor dilution signals detected
model est. 16%
💰 Capital Raise model 33%
• Under 12 months cash (8mo)
• Active ATM program with $50M remaining capacity
🔔 Track SANA — Get forecast alerts →

Market Data

Market Cap$784.32M
Shares Outstanding299.36M
Float169.91M
Cash$160.49M
Debt$82.63M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore46/100DilutionWatch score record
Shares Outstanding299.36MVerified float table or market cache
Public Float169.91MVerified float table or market cache
Market Cap$784.32MMarket data cache
Cash Runway8.3 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM Capacity$50.00MSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 6.

Recent SEC source mix: 4 2, 424B5 1, 8-K 1, SC 13G/A 1, XBRL 1.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 13.0% shares (2026Q1 vs prior)
201 institutional holders · 182.21M shares
#1 FMR LLC 37.43M shares
#2 Flagship Pioneering, LLC 25.00M shares
#3 VANGUARD CAPITAL MANAGEMENT LLC 14.87M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest38.73M
Days to Cover9.0
% of Float22.8%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2024-02-29
4 INSIDER TRANSACTION 2026-10-06
4 INSIDER TRANSACTION 2026-08-27
SC 13G/A BENEFICIAL OWNERSHIP 2026-08-14
8-K 8K EVENT 2026-04-13
Full SEC filing analysis available with free account →

Recent News

Factual SANA Dilution Snapshot

Sana Biotechnology, Inc. (SANA) has a DilutionScore of 46/100, rated Medium dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

SANA's DilutionScore is currently 46/100 (Medium risk), with 1 score change tracked over 89 days. The score deteriorated from 50/100 (Medium risk).

Period Score Risk Level Duration
Aug 22 – Oct 13, 202646/100MEDIUM53 days
Jul 16 – Aug 21, 202650/100MEDIUM36 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

SANA shares outstanding have increased 4.5% from 266.37M (Mar 2026) to 278.29M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 24, 2026278.29M169.91M▼ 9.94%
May 17, 2026278.29M188.67M▲ 0.14%
May 13, 2026278.29M188.41M▲ 4.28%
May 09, 2026269.99M180.67M▲ 1.34%
May 04, 2026269.99M178.28M▼ 0.79%
Apr 27, 2026269.99M179.69M▼ 0.02%
Apr 21, 2026266.87M179.72M▲ 1.38%
Apr 03, 2026266.87M177.28M▼ 0.06%
Mar 26, 2026266.87M177.38M▼ 0.04%
Mar 07, 2026266.37M177.46M▲ 0.09%
Mar 05, 2026266.37M177.29M▲ 0.19%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track SANA Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment SANA files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking SANA — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for SANA
SANA FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.